Stocks to Watch Today on February 19 are led by regulatory approvals in the pharmaceutical sector, a debarment order affecting infrastructure companies, large capital expenditure commitments in FMCG, and multiple order wins across engineering and renewable energy segments. As the share market today opens, investors are tracking corporate disclosures that could influence sector-specific sentiment and near-term trading activity.
Share Market News – Highlights
- Regulatory & Compliance Developments
- Infrastructure & Engineering Orders
- Capex Plans & Strategic Investments
- Manufacturing & Global Milestones
- Rights Issues & Capital Raising
- Institutional & Block Deals
- Companies Announcing Earnings Today
- Market Context & Sectoral View
Regulatory & Compliance Developments
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Bosentan tablets for oral suspension (32 mg), indicated for the treatment of pulmonary arterial hypertension. The product will be manufactured at the group’s SEZ formulation facility in Ahmedabad, strengthening its regulated markets portfolio.
Alembic Pharmaceuticals completed an unannounced USFDA cGMP inspection at its injectable facility in Karakhadi. The inspection concluded with two observations, neither related to data integrity, according to the company’s disclosure.
NCC and its step-down subsidiary O B Infrastructure have received a two-year debarment order from the National Highways Authority of India (NHAI), effective February 17, 2026. The order restricts participation in new NHAI tenders during the specified period. The company clarified that ongoing projects and the existing order book remain unaffected and stated it is reviewing the order under applicable legal provisions.
Jindal Saw reported that certain non-conformances were identified during an American Petroleum Institute (API) audit, leading to a suspension letter restricting the use of the API monogram on its seamless pipes. The company indicated that corrective measures are underway and noted that manufacturing capacity can be allocated to other product categories.
Infrastructure & Engineering Orders
Cochin Shipyard has entered into a contract exceeding ₹2,000 crore with France-based CMA CGM for the design and construction of six LNG-powered feeder container vessels, each with a capacity of approximately 1,700 TEU. The first vessel is expected to be delivered within 36 months, with subsequent deliveries scheduled over a 64-month timeline.
BL Kashyap and Sons secured a ₹300 crore contract from CRC Greens for civil structural works and supervision of a group housing project in Greater Noida, Uttar Pradesh.
Pace Digitek’s material subsidiary, Lineage Power, received a purchase order valued at $1.35 million from Saudi Arabia-based Yaqin Chem for the supply of a mobile Battery Energy Storage System (BESS).
RNIT AI Solutions received a pilot work order from the Government of Meghalaya for integrating its Face Recognition System with Meghalaya ONE and CM Connect applications. The order value is up to ₹1 crore.
Capex Plans & Strategic Investments
Hindustan Unilever’s board approved an investment of approximately ₹2,000 crore over two years to expand manufacturing capacity in premium segments within beauty & wellbeing and home care categories. The planned investment reflects a focus on high-growth product lines.
Dr Reddy’s Laboratories signed a definitive agreement with UK-based Mercury Pharma Group to acquire the trademarks Progynova and Cyclo-Progynova, along with related assets in India, for $32.15 million. The acquisition strengthens the company’s portfolio in women’s health therapies.
Manufacturing & Global Milestones
TVS Motor Company achieved a production milestone of one million vehicles in Indonesia since commencing operations 19 years ago. Approximately 95 percent of total output comprises two-wheelers, while the remaining production relates to three-wheelers.
Rights Issues & Capital Raising
Hilton Metal Forging’s board approved a rights issue of 1.67 crore equity shares priced at ₹16.68 per share, aggregating to ₹27.97 crore, to eligible shareholders as of the record date.
Institutional & Block Deals
In Capri Global Capital, BNP Paribas Financial Markets acquired 30.78 lakh shares representing 0.32 percent of paid-up equity from Morgan Stanley Asia (Singapore) at ₹176.2 per share.
Other institutional transactions were observed in select mid-cap counters, reflecting active portfolio adjustments by domestic and global investors.
Companies Announcing Earnings Today
ABB India, CIE Automotive India, Mahesh Developers, and Sattva Sukun Lifecare are scheduled to release their quarterly earnings during today’s trading session.
Market Context & Sectoral View
Pharmaceutical companies remain in focus amid regulatory clearances and inspection updates. Infrastructure and engineering stocks are reacting to order inflows and compliance developments, while FMCG companies are highlighting capital expenditure plans aimed at premiumization.
Additionally, SAIL and Sammaan Capital remain on the F&O ban list as per exchange disclosures.
Easy & quick
Leave A Comment?